Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Business Wire•13/11/2026•16:05 ET
0
Key Highlights
- ➤194,335 RSUs granted to 25 newly hired non-executive employees
- ➤RSUs vest 25% annually, subject to continued employee service
- ➤Awards approved under Evolus’ 2023 Inducement Incentive Plan
- ➤Grants made under Nasdaq Listing Rule 5635(c)(4)
Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Evolus, Inc. (NASDAQ: EOLS), a global performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant during August 2026 to November 2026 of an aggregate of 194,335 restricted stock units (RSUs) of the company’s common stock to 25 newly hired non-executive employees.
Get started
Create a free account to read the full story.